Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,018,925
+$646,762 QoQ
Shares Held
11,997
+10.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,649
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keel Point, LLC holds $22,441,479 across 10 Drug Manufacturers - General names. ABBV ranks #4 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,474 | $6,215,661 | |
| 2 | MRK |
Merck & Co., Inc.
|
36,633 | $4,707,340 | |
| 3 | LLY |
ELI LILLY & Co
|
3,650 | $4,377,919 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
11,997 | $3,018,925 | |
| 5 | NVS |
Novartis AG
|
6,229 | $976,208 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,068 | $892,971 | |
| 7 | AMGN |
Amgen Inc
|
2,204 | $798,112 | |
| 8 | AZN |
Astrazeneca PLC
|
3,042 | $576,824 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,018,925 | 11,997 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,372,163 | 10,907 | Shares | Sole | 2026-06-01 | |
| 2025-12-31 | $2,703,036 | 11,830 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,747,916 | 11,868 | Shares | Sole | 2025-12-16 | |
| 2025-06-30 | $2,219,087 | 11,955 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,405,080 | 11,479 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,825,867 | 10,275 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,904,102 | 9,642 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,572,666 | 9,169 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,137,032 | 6,244 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $898,671 | 5,799 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $822,662 | 5,519 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $654,248 | 4,856 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $838,604 | 5,262 | Shares | Sole | 2023-04-03 | |
| 2022-12-31 | $592,947 | 3,669 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $403,435 | 3,006 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $456,723 | 2,982 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $410,786 | 2,534 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $332,136 | 2,453 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $245,404 | 2,275 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $264,140 | 2,345 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $253,559 | 2,343 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $220,836 | 2,061 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||